ATE321885T1 - Modulation der neurokrinen differenzierung durch protein 25.1 - Google Patents

Modulation der neurokrinen differenzierung durch protein 25.1

Info

Publication number
ATE321885T1
ATE321885T1 AT00975512T AT00975512T ATE321885T1 AT E321885 T1 ATE321885 T1 AT E321885T1 AT 00975512 T AT00975512 T AT 00975512T AT 00975512 T AT00975512 T AT 00975512T AT E321885 T1 ATE321885 T1 AT E321885T1
Authority
AT
Austria
Prior art keywords
differentiation
neurocrine
modulation
protein
cancer
Prior art date
Application number
AT00975512T
Other languages
English (en)
Inventor
Elizabeth Wilson
Ron G Rosenfeld
Youngman Oh
Original Assignee
Univ Oregon Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oregon Health Sciences filed Critical Univ Oregon Health Sciences
Application granted granted Critical
Publication of ATE321885T1 publication Critical patent/ATE321885T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00975512T 1999-10-29 2000-10-30 Modulation der neurokrinen differenzierung durch protein 25.1 ATE321885T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16239399P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
ATE321885T1 true ATE321885T1 (de) 2006-04-15

Family

ID=22585428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00975512T ATE321885T1 (de) 1999-10-29 2000-10-30 Modulation der neurokrinen differenzierung durch protein 25.1

Country Status (6)

Country Link
EP (1) EP1226279B1 (de)
JP (1) JP2003513641A (de)
AT (1) ATE321885T1 (de)
CA (1) CA2389575A1 (de)
DE (1) DE60027042D1 (de)
WO (1) WO2001032925A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094059A1 (en) * 2004-09-22 2006-05-04 Odyssey Thera, Inc. Methods for identifying new drug leads and new therapeutic uses for known drugs
CN108778508B (zh) * 2016-01-14 2022-09-13 欧洲分子生物学实验室 配体诱导的细胞表达的微流体分析

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121416A (en) * 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules

Also Published As

Publication number Publication date
EP1226279A4 (de) 2003-06-04
JP2003513641A (ja) 2003-04-15
WO2001032925A9 (en) 2002-08-08
EP1226279A1 (de) 2002-07-31
WO2001032925A1 (en) 2001-05-10
DE60027042D1 (de) 2006-05-18
CA2389575A1 (en) 2001-05-10
EP1226279B1 (de) 2006-03-29

Similar Documents

Publication Publication Date Title
ATE427354T1 (de) Mage-a3 polypeptide die durch hla-klasse ii molekule prasentiert werden
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
ATE421537T1 (de) Erkennungsmoleküle zur behandlung und detektion von tumoren
CA2438143A1 (en) Modified proteins, designer toxins, and methods of making thereof
DE69737788D1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
AR026946A1 (es) Osteoprotegerina/receptores de factores de necrosis de tumores
DE60136099D1 (de) Zusammensetzungen zur behandlung und diagnose von eierstockkrebs
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
CY1111906T1 (el) Αντιγονο ογκων χρησιμο για τη διαγνωση και θεραπεια καρκινου του προστατη και του παχεος εντερου
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
AU9021898A (en) Prostate tumor polynucleotide and antigen compositions
ATE439369T1 (de) Methode und zubereitung zur hemmung von angiogenese
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
IRUELA‐ARISPE et al. Antiangiogenic domains shared by thrombospondins and metallospondins, a new family of angiogenic inhibitors
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
DK0889969T3 (da) Rekombinante adenovirale til genterapi af humane tumorer
ATE321885T1 (de) Modulation der neurokrinen differenzierung durch protein 25.1
WO2004012673A3 (en) Methods and reagents relating to inflammation and apoptosis
NO20002412L (no) FremgangsmÕte for behandling av tumorer og tumorceller ved anvendelse av ex vivo aktiverte T celler
EP1655382A3 (de) Dickdarm spezifisches Gen und Protein
DE60109359D1 (de) Verwendung von anti-ferritin antikörper bei der behandlung von bestimmten krebsarten
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties